Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Boucher

Showing results (21-30 of 310) with videos related to

Pageof 31
Sort By:
Chest|February 1, 1989
Intravenous dipyridamole infusion causes severe bronchospasm in asthmatic patientsK A Eagle, C A Boucher
Nederlands Tijdschrift Voor Geneeskunde|May 9, 2000
[Dendritic cells as carriers of human immunodeficiency virus (HIV)]J C Borleffs, C A Boucher
American Heart Journal|February 1, 1987
Differentiation of viable and nonviable myocardium after acute reperfusion using serial thallium-201 imagingR D Okada, C A Boucher
The American Journal of Cardiology|April 1, 1982
Radionuclide angiographyH W Strauss, C A Boucher
Proceedings. Biological Sciences|July 22, 1996
Anti-CD4 therapy for AIDS suggested by mathematical modelsR J De Boer, C A Boucher
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1987
Correlates of lung/heart ratio of thallium-201 in coronary artery diseaseS Homma, S Kaul, C A Boucher
Biotechniques|August 1, 1995
Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reactionM Nijhuis, C A Boucher, R Schuurman
AIDS (London, England)|February 24, 2001
HIV resistance assay results and their effect on therapeutic decisionsM Mascolini, A M Wensing, C A Boucher
IAPAC Monthly|November 8, 2001
How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 cliniciansM Mascolini, A M Wensing, C A Boucher
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1992
Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudineP Kellam, C A Boucher, B A Larder
Pageof 31

Showing results (21-30 of 310) with videos related to

Sort By:
Pageof 31
Chest|February 1, 1989
Intravenous dipyridamole infusion causes severe bronchospasm in asthmatic patientsK A Eagle, C A Boucher
Nederlands Tijdschrift Voor Geneeskunde|May 9, 2000
[Dendritic cells as carriers of human immunodeficiency virus (HIV)]J C Borleffs, C A Boucher
American Heart Journal|February 1, 1987
Differentiation of viable and nonviable myocardium after acute reperfusion using serial thallium-201 imagingR D Okada, C A Boucher
The American Journal of Cardiology|April 1, 1982
Radionuclide angiographyH W Strauss, C A Boucher
Proceedings. Biological Sciences|July 22, 1996
Anti-CD4 therapy for AIDS suggested by mathematical modelsR J De Boer, C A Boucher
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1987
Correlates of lung/heart ratio of thallium-201 in coronary artery diseaseS Homma, S Kaul, C A Boucher
Biotechniques|August 1, 1995
Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reactionM Nijhuis, C A Boucher, R Schuurman
AIDS (London, England)|February 24, 2001
HIV resistance assay results and their effect on therapeutic decisionsM Mascolini, A M Wensing, C A Boucher
IAPAC Monthly|November 8, 2001
How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 cliniciansM Mascolini, A M Wensing, C A Boucher
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1992
Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudineP Kellam, C A Boucher, B A Larder
Pageof 31